Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00609245 · ClinicalTrials.gov registry record · Phase 4
Effect of Valproic Acid Concentration on Photic Response
A Phase 4 study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 13
- Enrollment target
NCT00609245 is a Phase 4 study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 13 participants.
The verdict
NCT00609245, a Phase 4 study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 13 participants
- Enrollment target
Study Summary
We are trying to learn if small changes in the amount of a valproate in the blood (given through an IV) will change the way the brain reacts to flashing lights.
Interventions
- DRUG Placebo
- DRUG Valproic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00609245
The ClinicalTrials.gov registry entry for NCT00609245 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00609245 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00609245 about?
NCT00609245 is a clinical study titled "Effect of Valproic Acid Concentration on Photic Response". We are trying to learn if small changes in the amount of a valproate in the blood (given through an IV) will change the way the brain reacts to flashing lights.
What is the current status of trial NCT00609245?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2007-12. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00609245?
The interventions under investigation include: Placebo (DRUG), Valproic Acid (DRUG).
Who is sponsoring clinical trial NCT00609245?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.